Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 10, 2018 16:01 ET | Source: CRISPR Therapeutics AG; Vertex Pharmaceuticals Incorporated

CRISPR Therapeutics and Vertex Announce FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease

ZUG, Switzerland and BOSTON and CAMBRIDGE, Mass., Oct. 10, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based...
October 02, 2018 07:00 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics to Present at the Chardan Genetic Medicines Conference

ZUG, Switzerland and CAMBRIDGE, Mass., Oct. 02, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
September 20, 2018 20:33 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares

ZUG, Switzerland and CAMBRIDGE, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for...
September 19, 2018 16:08 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics Announces Proposed Public Offering of Common Shares

ZUG, Switzerland and CAMBRIDGE, Mass., Sept. 19, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for...
September 17, 2018 08:00 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics and ViaCyte Announce Strategic Collaboration to Develop Gene-Edited Stem Cell-Derived Therapy for Diabetes

- Aims to develop an immune-evasive stem cell therapy as a potentially curative treatment for diabetes - - Parties will collaborate through commercialization and share costs and profits worldwide - ...
August 30, 2018 07:00 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics to Present at Upcoming Investor Conferences

ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 30, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
August 07, 2018 17:01 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2018 Financial Results

-Obtained Approvals of CTAs in Multiple Countries for CTX001 in β-thalassemia and SCD--Initiation of Clinical Trials for CTX001 in β-thalassemia and SCD on Track for 2018--Preclinical Studies for...
June 05, 2018 08:00 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics to Participate in Three June Conferences

ZUG, Switzerland and CAMBRIDGE, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
May 30, 2018 16:30 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics and Vertex Provide Update on FDA Review of Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease

BOSTON and ZUG, Switzerland and CAMBRIDGE, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) today announced that the...
May 15, 2018 08:00 ET | Source: CRISPR Therapeutics AG

CRISPR Therapeutics Announces Presentations at the ASGCT 21st Annual Meeting

ZUG, Switzerland and CAMBRIDGE, Mass., May 15, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...